Robert E. Hoffman insider trades

Open-market stock purchases and sales by Robert E. Hoffman, Chief Executive Officer at CytoDyn Inc, from SEC Form 4 filings since Feb 15, 2022.

Recent trades

DateStockTradeValue
Oct 20, 2026CYDY CytoDyn IncBought (not open market)—
Jul 13, 2026ESPR Esperion Therapeutics, IncSold (not open market)—
Jul 13, 2026ESPR Esperion Therapeutics, IncSold (not open market)$56.4K
Jul 13, 2026ESPR Esperion Therapeutics, IncSold (not open market)$6.1K
Jun 23, 2026FBLG FibroBiologics, IncBought (not open market)—
May 28, 2026ESPR Esperion Therapeutics, IncBought (not open market)—
Mar 20, 2026CYDY CytoDyn IncBought (not open market)—
Feb 12, 2026HURA TuHURA Biosciences, Inc./NVBought (not open market)—

Companies traded

  • CYDY CytoDyn Inc: other filings, last Oct 20, 2026
  • ESPR Esperion Therapeutics, Inc: other filings, last Jul 13, 2026
  • FBLG FibroBiologics, Inc: other filings, last Jun 23, 2026
  • HURA TuHURA Biosciences, Inc./NV: other filings, last Feb 12, 2026
  • KTRA Kintara Therapeutics, Inc: 1 buy, last Aug 30, 2023

Get free alerts when Robert E. Hoffman files a new trade →